U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173 books (1351 items)

1.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

2.
Endotext [Internet].

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

3.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

4.
5.
Bone Health and Osteoporosis: A Report of the Surgeon General.

Bone Health and Osteoporosis: A Report of the Surgeon General.

Office of the Surgeon General (US).

Rockville (MD): Office of the Surgeon General (US); 2004.

7.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

8.
Endocrinology: An Integrated Approach.

Endocrinology: An Integrated Approach.

Nussey S, Whitehead S.

Oxford: BIOS Scientific Publishers; 2001.

9.
Evidence review for monitoring: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review I.

Evidence review for monitoring: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review I.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

10.
11.
12.
13.
Evidence review for pregnancy: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review J.

Evidence review for pregnancy: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review J.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

14.
Evidence review for Diagnostic Tests: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review B.

Evidence review for Diagnostic Tests: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review B.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

15.
Evidence review for surgical localisation: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review D.

Evidence review for surgical localisation: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review D.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

16.
Evidence review for indications for diagnostic testing: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review A.

Evidence review for indications for diagnostic testing: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review A.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

17.
Evidence review for indications for surgery: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review C.

Evidence review for indications for surgery: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review C.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

18.
Evidence review for surgical interventions: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review E.

Evidence review for surgical interventions: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review E.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

19.
Evidence review for calcimimetics: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review G.

Evidence review for calcimimetics: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review G.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

20.
Evidence review for bisphosphonates: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review H.

Evidence review for bisphosphonates: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review H.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 132.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • Figure 1.
  • Figure 17.
  • Figure 5.
  • Figure 6.
See more (169)...

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...